Skip to main content
Clinical Trials/IRCT20211121053127N1
IRCT20211121053127N1
Recruiting
Phase 2

Evaluation of the effectiveness of injectable transamine administration in reducing the volume of bleeding in open trans-vesicular prostatectomy in patients with benign prostatic hyperplasia

Esfahan University of Medical Sciences0 sites70 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Benign prostate enlargement.
Sponsor
Esfahan University of Medical Sciences
Enrollment
70
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing Prostatectomy
  • Patients who are willing to participate in the study

Exclusion Criteria

  • Use of anticoagulants such as aspirin and dipyridamole
  • Prothrombin time and partial thromboplastin time are high for whatever reason
  • Any history of thrombotic events
  • History of bleeding disorders
  • Chronic kidney disease (serum creatinine greater than 180 micromoles per liter).

Outcomes

Primary Outcomes

Not specified

Similar Trials